Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.
about
Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic reviewSafety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.Impact of pneumococcal conjugate vaccination on otitis media: a systematic reviewThe Saudi Thoracic Society pneumococcal vaccination guidelines-2016.Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.Expanding prevention of invasive meningococcal disease.Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makersSystematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.Antibiotic treatment of acute otitis media in pediatrics.Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.Prevalence of Human Bocavirus in Africa and Other Developing Countries between 2005 and 2016: A Potential Emerging Viral Pathogen for Diarrhea
P2860
Q26796334-9FC3F2C1-D554-40D4-B284-00EC1002FF51Q33909172-8E3205C6-C185-4EA0-8DDF-B76723A11009Q34407129-84E73DDE-9BA7-45D8-86A1-A239EB52AA3FQ35977422-150B8311-8D58-4B51-A4AA-DB99F226C7B1Q36861485-84AF38F6-0383-4088-A643-C570B5B107D6Q37316015-E683FB3F-AE7E-4FDD-9B68-39ACEA3E8C87Q37503239-6C2053F2-0E2C-42B2-A5FB-76CB5D552588Q37608307-D159CD0C-4639-432D-95C0-28EEE7D341B3Q37613616-BD8E342E-4108-4443-9330-C37933350A2AQ37621054-AF2BB837-2760-4BD2-9E6B-3B8AEF9A6374Q39749485-36A1F145-CE89-4016-B9DB-D80E28DCC560Q45823762-AD6A3EE0-FAA9-4141-90A5-052FFA4CAC93Q51168324-ACF9BB60-C2F3-4E01-880F-87CA63F6F89CQ57112691-93989BAB-AD40-4895-A871-37B9B075BC68
P2860
Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@ast
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@en
type
label
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@ast
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@en
prefLabel
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@ast
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@en
P2093
P2860
P356
P1433
P1476
Impact on respiratory tract in ...... at 3, 5 and 11 months of age.
@en
P2093
Alessandro Lizioli
Alessandro Rognoni
Annalisa Lastrico
Claudia Tagliabue
Enrica Begliatti
Laura Cesati
Susanna Esposito
Vittorio Carreri
P2860
P2888
P356
10.1186/1465-9921-8-12
P577
2007-02-21T00:00:00Z
P5875
P6179
1043878044